Janus Henderson Group’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
Other funds holding TNGX
SL
Janus Henderson Group's TNGX Position: Q3 2026 in Review
Janus Henderson Group opened a new position in Tango Therapeutics (TNGX) in Q3 2026: 4,942,732 shares worth $123M. The stake represents 0.05% of the portfolio and ranks #271 among its holdings. This is a return to the name: Janus Henderson Group previously reported a position in TNGX as recently as Q1 2026.
Janus Henderson Group first reported a position in TNGX in Q3 2020 and has held it in 18 quarters since. 257 funds tracked by Wall St. Rank hold TNGX as of Q3 2026.
- Janus Henderson Group held 4,942,732 shares of Tango Therapeutics worth $123M as of Q3 2026.
- Tango Therapeutics was a new Janus Henderson Group position in Q3 2026.
- Tango Therapeutics made up 0.05% of Janus Henderson Group's portfolio in Q3 2026, its #271 holding.
- Janus Henderson Group first reported a position in Tango Therapeutics in Q3 2020 and has held it in 18 quarters since.
- 257 funds tracked by Wall St. Rank held Tango Therapeutics as of Q3 2026.
Based on Janus Henderson Group's 13F filing for Q3 2026, filed 16 Nov 2026.